Supplements · Cardiology · Meta-analysis

Omega-3 and the Heart: Real Benefit, With a Catch

CEBM 1a ★★★★☆ 4 / 5 42 RCTs and 176,253 participants: a high level of evidence, but with a safety signal and inconsistency across doses.

Omega-3 is one of the most popular "heart-healthy" supplements. A meta-analysis of 42 RCTs and 176,253 people shows the benefit is real, yet not unconditional, and the form of the acid matters more than the simple fact of taking it.

What they found

EPA reduced cardiovascular mortality by 6%, the risk of fatal heart attack by 39%, and coronary events by 27%. Pure EPA worked better than the EPA+DHA combination.

The flip side

The benefit comes at a price: the same use raised the risk of atrial fibrillation.

+22%

higher risk of atrial fibrillation with omega-3 (up to +50% for pure EPA). The heart benefit and the arrhythmia risk come in the same bottle.

Why it matters

"Omega-3" on the label is no guarantee of an effect. What counts is the form (EPA versus DHA), the dose, and a person's baseline risk. For a healthy person with no indication, it may simply not be needed.

An honest caveat

The optimal dose was never pinned down, and the studies are heterogeneous. The arrhythmia signal calls for caution in those who are predisposed.

The bottom line

Omega-3 is not a "just in case" vitamin but a drug with a benefit/risk profile. The decision should be made for the individual, not for the trend.

Source: meta-analysis, 2025 (42 RCTs, 176,253 participants)

View on PubMed ↗